Skip to main content
Fig. 6 | BMC Infectious Diseases

Fig. 6

From: Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients

Fig. 6

The alterations of parameters related to liver function with increased delayed hospitalization. The alteration of ALT level with increased delayed hospitalization in total (A), mild (B), and severe (C) COVID-19 patients; The alteration of AST level with increased delayed hospitalization in total (D), mild (E), and severe (F) COVID-19 patients; The alteration of DBil level with increased delayed hospitalization in total (G), mild (H), and severe (I) COVID-19 patients; The alteration of albumin level with increased delayed hospitalization in total (J), mild (K), and severe (L) COVID-19 patients. The trend tests were analyzed with rank correlation using the Spearman method. *P < 0.05, **P < 0.01, and ***P < 0.001; NS, not significant. Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBil, direct bilirubin

Back to article page